SRL
NVAX icon

Scientech Research LLC’s Novavax NVAX Stock Holding History

Scientech Research LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,353
Closed -$141K – 452
2026
Q1 		$141K Buy
17,353
+551
+3% +$5K 0.12% 305
2025
Q4 		$113K Buy
16,802
+5,735
+52% +$43.2K 0.07% 394
2025
Q3 		$96K Buy
+11,067
New +$86.1K 0.03% 499
2024
Q3 		– Sell
-17,164
Closed -$217K – 769
2024
Q2 		$217K Sell
17,164
-23,391
-58% -$235K 0.04% 518
2024
Q1 		$194K Buy
+40,555
New +$188K 0.1% 372

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Scientech Research LLC's NVAX Position: Q2 2026 in Review

Scientech Research LLC sold out of Novavax (NVAX) in Q2 2026, closing a stake of 17,353 shares — an estimated $141K sold.

Scientech Research LLC first reported a position in NVAX in Q1 2024 and held it in 5 quarters. The position peaked at $217K in Q2 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Scientech Research LLC reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 17,353 Novavax shares in Q2 2026, an estimated $141K.
  • Scientech Research LLC first reported a position in Novavax in Q1 2024 and held it in 5 quarters.
  • Scientech Research LLC's Novavax position peaked at $217K in Q2 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.